missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ OPRD1 Polyclonal Antibody

Description
Antibody detects endogenous levels of total OPRD1.
OPRD1 is an Opioid Receptor that is involved in the control of anxiety, depression, and pain. It is a promising target in the therapy of mood-altering disorders and drug addiction. Delta and kappa opioid receptors function synergistically by forming heterodimers. OPRD1 expression has been reported primarily in the brain. High OPRD1 expression has been documented in the cortex, caudate, hippocampus, nucleus accumbens, and putamen; low OPRD1 expression has been identified in the cerebellum, hypothalamus, substantia nigra, and thalamus. OPRD1 expression is reduced in the putamen and amygdala of Alzheimer's patients and in the putamen in Parkinson's disease.
Specifications
Specifications
| Antigen | OPRD1 |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 |
| Gene | OPRD1 |
| Gene Accession No. | P32300, P41143 |
| Gene Alias | delta 1 opioid receptor; delta opioid receptor 1; delta-type opioid receptor; DOR; D-OR-1; DOR-1; K56; mDOR; MSL-2; Nbor; Opioid receptor; opioid receptor A; opioid receptor delta 1; opioid receptor, delta 1; OPRD; Oprd1; Ror-a |
| Gene Symbols | OPRD1 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?